Florida Myeloma Community Event: Understanding Different Classes of Myeloma Treatments with Dr. Rachid Baz image

Florida Myeloma Community Event: Understanding Different Classes of Myeloma Treatments with Dr. Rachid Baz

Jan 24, 2023
06:30PM - 08:00PM EST
Online Event
Overview

The Florida Myeloma Community has invited Dr. Rachid Baz, myeloma specialist and leader at Moffitt Cancer Center to speak on the different classes of myeloma drugs and how they are combined for effective treatment against the myeloma. A Q&A session will follow the presentation, so come prepared! We look forward to learning with you.

Agenda
06:30 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Rachid Baz.

06:35 PM
Member Spotlight
Dina Myers Roosth
06:40 PM
Presentation
Dr. Rachid Baz

Dr. Rachid Baz shares on the different classes of myeloma drugs and how they are combined for effective treatment against the myeloma

07:10 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!
07:40 PM
Announcements and Post Meeting Mingle
Audience
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Dr. Rachid Baz

Dr. Rachid Baz

Dr. Rachid Baz is a board-certified hematologist and medical oncologist who came to Moffitt in 2008 from Cleveland Clinic. Currently, Dr. Baz is Myeloma Section Head in the Department of Malignant Hematology at Moffitt Cancer Center. In addition, he is the Director of Clinical Research in the Malignant Hematology Department. Dr. Baz is also a Director of the Myeloma Research Center. He has developed a special expertise in managing patients with plasma cell disorders such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, primary systematic amyloidosis, and Waldenstrom’s macroglobulinemia (WM). Among other awards, he was the recipient of the Junior Clinical Science Award at Moffitt, and the University of South Florida Outstanding Resident Teaching Award.